Pharmacovigilance Europe 2016, London: 24-15 May 2016
Dr. Pipasha Biswas from Symogen will be speaking at this conference on the following topics:
"Using pharmacovigilance databases to facilitate the detection of adverse events
and the generation of safety signals."
Pipasha Biswas, Director & QPPV, Pharmacovigilance & Pharmacoepidemiology, Symogen
Panel Discussion - Patient Support Programme
Moderator : Dr Paul Tunnah, CEO, Pharmaphorum
Pipasha Biswas, Director & QPPV, Pharmacovigilance & Pharmacoepidemiology,Symogen
Shelley Gandhi, Director Pharmacovigilance and Drug Safety, NDA Group AB, UK
Miranda Dollen, Vice President, Pharmacovigilance, Mapi Group
EXPERTS IN PHARMACOVIGILANCE...
Symogen is a niche service provider for all aspects of Pharmacovigilance, Pharmacoepidemiology, Medical Writing & Regulatory Services.
Established in 2007, our clients are large and midsize pharmaceutical and biotech companies.
Symogen Limited is 9001:2008 (Quality Management Systems) and ISO 22301:2012 (Business Continuity Strategy) certified.